Applications published 23 September 2009

Compounds and formulations suitable for radical scavenging
Solenne 2101574*

ACE2 activator compounds and methods of use thereof
University of Florida Research Foundation 2101575*

Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4,3-B) indoles (variants), pharmacological means based thereon and methods for the use thereof
Medivation Neurology 2101578*

Means for inducing cognitive functions and memory based on hydrogenated pyrido (4,3-B) indoles (variants), pharmacological means based thereon and methods for the use thereof
Medivation Neurology 2101579*

Methods of use for cyclopamine analogues
Infinity Discovery; Johns Hopkins University 2101580*

Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
Cenerx Biopharma 2101585*

Compounds, compsns, kits and methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analogue with or without a reyinoid
Wisconsin Alumni Research Foundation 2101727*

Dispersion of polyamino acids in a continuous lipid phase
Flamel Technologies 2101728*

Self-microemulsifying drug delivery systems
Lek Pharmaceuticals 2101729*

Galenic form for the transmucosal delivery of paracetamol
Pervitch, Philippe; Maury, Marc 2101730*

Endoxifen methods and compsn
Jina Pharmaceuticals 2101731*

Liposomal gel phthalocyanine preparation for photodynamic therapy of tumours and its manufacturing
Institute of Physiology of ASCR; RCD 2101732*

Powder formulations for valganciclovir
F Hoffmann-La Roche 2101733*

Vesicles of self-assembling block copolymers and methods for making and using the same
The Regents of the University of California 2101734*

Nanoparticulate formulations and methods for the making and use thereof
Marinus Pharmaceuticals 2101735*

Homogeneous paste and gel formulations
Merial 2101736*

Revaprazan-containing solid dispersion and process for the preparation thereof
Yuhan Corp 2101737*

Compsn and method for preparing orally disintegrating tablets
Mallinckrodt 2101738*

Compsn and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
Mallinckrodt 2101739*

New non-abusable pharmaceutical compsn comprising opioids
Orexo 2101740*

Solid dispersion containing a poorly water soluble drug
Bend Research 2101741*

Pharmaceutical compsn containing clopidogrel hydrogene-sulphate of polymorph 1 form
Egis Gyoguszergyar Nyilvanosan Mukoedo Reszventyarsasag 2101742*

Extended release excipient and its use
Campina Nederland Holding 2101743*

Oral transmucosal nicotine dosage form
Cima Labs 2101744*

Delivery of drugs
Landec 2101745*

V3 antagonists for the treatment or prevention of chronic pain
NV Organon 2101746*

Cancer chemoprevention strategy based on loss of imprinting of IGF2
The Johns Hopkins University; The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 2101747*

Use of incensole, incensole acetate and derivatives thereof
Yissum Research Development Company of the Hebrew University of Jerusalem; Ariel-University Research and Development 2101748*

Pharmaceutical compsn comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof
Jin-Do County 2101749*

Water-soluble phenicol prodrugs in a lipophilic vehicle system
Schering-Plough 2101750*

Benzamide derivatives as EP4 receptor agonists
Glaxo Group 2101751*

Use of prodrugs of GABA analogues for treating diseases
XenoPort 2101752*

Use of cytohesin inhibitors for chemically inducing longevity
Rheinische Friedrich-Wilhelms Universitaet 2101753*

Use of entacapone in cosmetic, dermatological and pharmaceutical compsns
Revotar Biopharmaceuticals 2101754*

Polyalkyloxydibenz (C,E) oxepine derivatives as medicaments
The University of Manchester 2101755*

Method of treating hyperesthesia, parenthesia, dolor and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
Parks, Jeffery; Parks, L Dean 2101756*

Compound for treatment or prevention of prostate-related diseases and pharmaceutical compsn of colon delivery system containing the same
Mazence; KT&GCo 2101757*

Methods of using MEK inhibitors
Exelixis 2101758*

Methods of using MEK inhibitors
Exelixis 2101759*

Use of unit dose formulations and methods of treating thrombosis with and oral factor XA inhibitor
Millennium Pharmaceuticals 2101760*

Methods for preserving renal function using xanthine oxidoreductase inhibitors
Takeda Pharmaceuticals 2101761*

Novel 2-imidazoles as ligands for trace amine associated receptors (TAAR)
F Hoffmann-La Roche 2101762*

Pharmaceutical compsns and their methods of use
Abbott Laboratories 2101763*

Desferrithiocin analogue actinide decorporation agents
University of Florida 2101764*

Use of epithilones in the treatment of osteoporosis and related diseases
Bayer Schering 2101765*

Compsns and methods of using (R)-pramipexole
Knopp Neurosciences 2101766*

An article comprising prasugrel
Eli Lilly 2101767*

Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases
Les Laboratoires Servier 2101768*

Methods of the treatment of alcohol abuse, addiction and dependency
Janssen Pharmaceutica 2101769*

Medicinal delivery system and related methods
JSR NTI LLC 2101770*

Stable lercanidipine formulation
Torrent Pharmaceuticals 2101771*

Intermediate duration neuromuscular blocking agents and antagonists thereof
Cornell Research Foundation 2101772*

(R)-N-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogues
Progenics Pharmaceuticals 2101773*

7,8-saturated-4,5-epoxy-morphinanium analogues
Progenics Pharmaceuticals 2101774*

Reduction of cardiovascular systems
CV Therapeutics 2101775*

Treatment of anxiety with eszopiclone
Sepracor 2101776*

Compsn for treating a pulmonary hypertension
Gilead Colorado 2101777*

Agent for treating vascular leaks
Bitop Aktiengesellschaft fuer Biotechnische Optimierung 2101778*

Medical implants with a combination of compounds
Angiotech Pharmaceuticals 2101779*

Methods of treating chronic inflammatory diseases using a GM-CSF?antagonist
Kalobios Pharmaceuticals 2101780*

Method for treating or preventing symptoms of hormonal variations
Yung Shin Pharmaceuticals Industrial Co 2101781*

Use of MTK1 for treating or preventing bone cancer
Janssen Pharmaceutica 2101782*

Method of preventing or treating myocardial ischaemia
Novartis 2101783*

Methods for determining prognoses and therapeutic interventions for ovarian carcinomas
The Regents of the University of Colorado 2101784*

Treatment for dry eye
Southern College of Optometry 2101785*

Medicaments and methods for promoting wound contraction
Renovo 2101786*

Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin
Drugrecure 2101787*

D-ribose for treating suboptimal pulmonary function
Bioenergy 2101788*

Combined telomerase inhibitor and gemcitabine for the treatment of cancer
Geron Corp 2101789*

Combination comprising CNDAC (2"-cyano-2"-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent
Cyclacel 2101790*

Anticonnexin polynucleotides as impaired wound healing compsns
Coda Therapeutics 2101791*

Use of carrageenan for treating rhinovirus infections
Marinomed Biotechnologie 2101792*

Composite material for tissue repair
Synthasome 2101793*

Inorganic solids that accelerate coagulation of blood
Honeywell 2101794*

Cellular preparations for use as a revascularisation stimulating agent
Institut des Vaisseaux et du Sang; Assistance Publique Hopitaux de Paris; Universite Paris 2101795*

Compsns and methods for the treatment of viral hepatitis
Hepc Biotechnologiai Kukato És Fejleszto Kft 2101797*

Topical treatment of acne with extracts of glycyrrhiza, foeniculum and atriplex, combined with minerals
Gonen, Shmuel 2101798*

Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissue in humans and animals
Nutramax Laboratories 2101799*

Extracts from the skin of fruits of plants from the genus vitis, compsns containing the same and a process for its manufacture
Ache Laboratòrios Farmaceuticos 2101800*

Oral delivery of polypeptides
Ablynx 2101801*

Inhibiting collagen-induced platelet aggregation and activation with peptide variants
University of Massachusetts Medical School 2101802*

Pro-angiogenic peptides
Susavion Biosciences 2101804*

Specific therapy and medicament using integrin ligands for treating cancer
Merck Patent 2101805*

Treatment of disease or injury of the nervous system using agents that decrease the activity of melanocortin 4 receptor
NeuroNova 2101806*

VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumours
Genentech 2101807*

Treatment of respiratory chain disorders using compounds having erythropoietin of thrombopoietin activity
Edison Pharmaceuticals 2101808*

Pharmaceutical compsn containing arazyme for the prevention of liver dysfunction
Insect Biotech 2101809*

Chymosin for the prevention and treatment of gastrointestinal disorders
OU Nutrichym 2101810*

Vaccine for periodontitis and methods of use
The Board of Regents of the University of Oklahoma 2101811*

Universal tumour cell vaccine for anti-cancer therapeutic and prophylactic utilisation
Novarx 2101812*

Novel glycosylated peptide target in neoplastic cells
Patrys 2101813*

Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
Glycotope 2101814*